Batefenterol
Iinkcukacha zeMveliso
Iithegi zeMveliso
Ubungakanani bePakethi | Ubukho | Ixabiso (USD) |
50mg | Ikhona evenkileni | 200 |
250mg | Ikhona evenkileni | 600 |
500mg | Ikhona evenkileni | 900 |
1g | Ikhona evenkileni | 1400 |
Iisayizi ezininzi | Fumana iiQuotes | Fumana iiQuotes |
Igama leMchiza:
"(R)-1-(3-((2-chloro-4-(((2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethyl)amino) methyl)-5-methoxyphenyl)amino)-3-oxopropyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate Batefenterol Succinate"
Ikhowudi yoncumo:
O=C(OC1CCN(CCC(NC2=CC(OC)=C(CNC[C@H](O)C3=CC=C(O)C4=C3C=CC(N4)=O)C=C2Cl)= O)CC1)NC5=CC=CC=C5C6=CC=CC=C6
Ikhowudi ye-InChi:
InChI=1S/C40H42ClN5O7/c1-52-36-22-33(31(41)21-26(36)23-42-24-35(48)2 9-11-13-34(47)39-30(29)12-14-37(49)45-39)43-38(50)17-20-46-18-15-27(1 6-19-46)53-40(51)44-32-10-6-5-9-28(32)25-7-3-2-4-8-25/h2-14,21-22, 27, 35,42,47-48H,15-20,23-24H2,1H3,(H,43,50)(H,44,51)(H,45,49)/t35-/m0/s1
Isitshixo se-InChi:
URWYQGVSPQJGGB-DHUJRADRSA-N
Igama elingundoqo:
Batefenterol, TD-5959, GSK961081, 743461-65-6, GSK-961081, GSK 961081, TD5959, TD 5959, 743461-65-6
Ukunyibilika:Inyibilika kwi-DMSO
Ugcino:0 - 4°C ixesha elifutshane (iintsuku ukuya kwiiveki), okanye -20°C ixesha elide (iinyanga)
Inkcazo:
I-Batefenterol ngumchasi we-muscarinic kunye ne-β2-adrenergic receptor (β2-AR) i-agonist (Kis = 1.4, 1.3, kunye ne-3.7 nM, ye-hM2, hM3, kunye ne-hβ2-AR, ngokulandelanayo kwi-assay yokubopha i-radioligand). I-Batefenterol ibonisa umsebenzi we-agonist onamandla we-hβ2-AR (EC50 = 0.29 nM) kunye ne-440- kunye ne-320-fold-fold function selectivity over hβ1- kunye ne-hβ3-ARs, ngokulandelanayo.1 I-Batefenterol yenza ukuphumla kwemisipha epholileyo (EC50 = 11 nM) kwi-tracheal guinea eyedwa. izicubu kwaye inqanda impendulo ye-bronchoconstrictor kwi-a i-guinea pig bronchoprotection assay (ED50 = 6.4 µg / mL). Iifomyula eziqulethe i-batefenterol zikulingo lwezonyango lokunyanga isifo esingapheliyo semiphunga (COPD).
Ithagethi: β2-adrenoceptor